One Step Closer
by melelllan on February 14, 2015
It is just after midnight and my girl is sleeping (thank goodness!!) and I wonder if her and other Rett children’s dreams just became filled with butterflies. Why butterflies? Because they are to me a most beautiful symbol of metamorphosis, of evolving, of change. Tonight, as she slept this came our way….
"FDA Search Orphan Drug Designations and Approvals" page
NNZ-2566 has been granted Orphan Drug Designation.
What does it mean? To be honest, more than I can understand. I know it means huge incentives for Neuren, with 7 years marketing exclusivity if (when!) the FDA approves it for use, tax breaks etc. but what I FEEL in my heart is that the FDA is acknowledging the Rett Community needs this, our children need hope, us parents need hope. And, I FEEL like a magician just placed a cocoon in his hand, blew in it, opened it up and a thousand butterflies filled the air…for there it is, in writing, by a FEDERAL AGENCY- “treatment of Rett Syndrome”.
The world is achanging and it’s a beautiful thing.
- Forums
- ASX - By Stock
- NEU
- FDA Grants Orphan Drug Designation
FDA Grants Orphan Drug Designation, page-24
-
- There are more pages in this discussion • 31 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NEU (ASX) to my watchlist
|
|||||
Last
$14.07 |
Change
-0.400(2.76%) |
Mkt cap ! $1.798B |
Open | High | Low | Value | Volume |
$14.47 | $14.53 | $13.99 | $7.843M | 552.7K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 2150 | $14.06 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$14.10 | 1129 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 2150 | 14.060 |
1 | 49 | 14.040 |
2 | 5301 | 14.010 |
6 | 5183 | 14.000 |
2 | 2328 | 13.990 |
Price($) | Vol. | No. |
---|---|---|
14.100 | 1129 | 2 |
14.120 | 493 | 1 |
14.140 | 1566 | 2 |
14.150 | 4156 | 2 |
14.170 | 600 | 1 |
Last trade - 16.10pm 03/09/2024 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |